The researchers spent 3 months on the summit of Monta Rosa (4559m) in the Alps and tested 262 climbers for HAPE.
They found that their theory about lung size was correct, but also that many of the climbers were suffering from sysmptons of the condition because they had ascended too quickly and were not properly acclimatised.
The study concludes that: 'The risk of HAPE might not be confined to a small group of genetically susceptible people, but likely exists for most climbers if the rate of ascent and degree of physical effort are great enough, especially if lung size is normal or low.'
But then we knew that didn't we?
This year's British Lead and Speed Climbing Championships and a round of the Paraclimbing Cup took place at Awesome Walls,... Read more
15 year old Laura Rogora, from Rome, Italy, has repeated Red Bull, 8c, at Collepardo, needing only three tries, making it her... Read more
James McHaffie had a productive weekend in North Wales, establishing an Ogwen highball arête named Devil's... Read more